Predict your next investment

Segra company logo
AGRICULTURE | Crop Production
segra-intl.com

See what CB Insights has to offer

Founded Year

2017

Stage

Unattributed - VII | Alive

Total Raised

$10.91M

Last Raised

$4.8M | 3 mos ago

About Segra

Segra is a plant biotechnology company that specializes in industrial-scale cannabis plant micropropagation also known as "plant tissue culture." The company is developing industrial-scale cannabis micropropagation laboratories to produce healthy, robust plantlets for licensed cannabis producers globally.

Segra Headquarter Location

#108 – 21300 Gordon Way

Richmond, British Columbia, V6W 1M2,

Canada

604-284-3204

Latest Segra News

Segra International completes first export of Cannabis plantlets from Canada to the USA

Jun 29, 2021

Richmond, British Columbia, CANADA VANCOUVER, British Columbia, June 29, 2021 (GLOBE NEWSWIRE) -- Segra International Corp, a leading cannabis agriculture technology company, is pleased to announce its first successful export of Verified Segra Stock™ Cannabis plantlets to the Biopharmaceutical Research Company (BRC), one of the first groups in the USA to receive approval from the DEA to cultivate Cannabis for scientific research purposes. This shipment marks a tremendous milestone in the evolution of the US cannabis industry, as it represents one of the first imports of live Cannabis plants to a federally licensed US cultivator. In recent months, the DEA has issued a select number of licenses to several groups in the US to allow for the cultivation of Cannabis for scientific research purposes. BRC, based in California, is among the first companies granted a license and is now operational. Segra’s Verified Segra Stock™ plantlets will provide BRC with standardized and validated starting materials produced through plant tissue culture and backed by extensive agronomic data and Cannabis plant pathogen screening. BRC works with research groups studying Cannabis and Cannabis flower to understand the plant in a scientific and federally regulated environment. Under the federal licensing regime, BRC is only allowed to source genetics and starting material from DEA-compliant or federally legal sources. “Segra's Verified Segra Stock™ guarantee means our plantlets are DNA fingerprinted and pathogen-free with virtually no risk of pathogen introduction to the receiving grow facility. Starting with this input material is critical to effectively grow replicable crops, something highly valued by researchers who are studying the finished product of the Cannabis plant and its derivatives," said Jamie Blundell, CEO of Segra International. "Furthermore, Segra's VNTR DNA Fingerprinting technology allows BRC to order plantlets and cultivars with certainty, knowing they are receiving the same input material with each shipment. The application of VNTR DNA fingerprinting technology can be used throughout the supply chain for track and trace purposes, from plantlet to flower, translating this certainty to researchers who can study the same product repeatedly." "At BRC, we are focused on developing federally compliant active pharmaceutical ingredients for federally compliant researchers examining the therapeutic effects of Cannabis" said George Hodgin, CEO of Biopharmaceutical Research Company. "We're fortunate to be working with Segra to offer our clients a wide range of clean, high-quality Cannabis of specific chemical expressions and flower types to help them better understand the applications of the Cannabis plant." Learn more about Segra's services and premium cultivars by viewing the 2021 Cultivar and Services Catalogue. About Segra:  Segra is an agriculture technology company offering plant tissue culture, plant genomics, and pathogen detection services to accelerate the advancement of the cannabis industry. The company's proprietary technologies empower its clients to drive financial performance and mitigate risk while exploring the next frontier of optimized cultivation practices for the rapidly evolving cannabis consumer. Segra has developed industrial-scale laboratories to produce Verified Segra Stock™, robust, and DNA-fingerprinted Cannabis plantlets for licensed producers globally. Segra has assembled a world-class team of specialists in agronomy, molecular genetics, plant tissue culture, and regulatory compliance to support this vision. Learn more at  segra-intl.com  or by viewing the  2021 Cultivar and Services Catalogue . About Biopharmaceutical Research Company BRC is a specialty pharmaceutical company that holds several DEA Registrations across the entire value chain of Cannabis and is pioneering the federally legal Cannabis space in the USA. Forward-Looking Information: This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan," "continue," "expect," "project," "intend," "believe," "anticipate," "estimate," "may," "will," "potential," "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as expressly required by applicable law.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Segra

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Segra is included in 3 Expert Collections, including Cannabis.

C

Cannabis

3,519 items

These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.

A

Advanced Manufacturing

1,063 items

A

Agriculture Technology (AgTech)

1,630 items

Companies that are using technology to make farms more efficient.

Segra Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Segra Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.